Markus Hörer
Founder bij FREELINE THERAPEUTICS HOLDINGS PLC
Profiel
Founder of Freeline Therapeutics Holdings Plc, Markus Hörer is Chief Technology Officer at this company and Co-Managing Director at Freeline Therapeutics GmbH.
Actieve functies van Markus Hörer
Bedrijven | Functie | Begin |
---|---|---|
FREELINE THERAPEUTICS HOLDINGS PLC | Founder | 01-01-2015 |
Freeline Therapeutics GmbH
Freeline Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Ascend Gene & Cell Therapies Ltd., Freeline Therapeutics GmbH is a German biotechnology company that focuses on liver directed gene therapies for bleeding disorders and other chronic diseases. The private company is based in Planegg, Germany. The company has a pipeline of gene therapies that have the potential to change the lives of people with chronic, debilitating diseases. Freeline has two key enabling platforms critical to realizing AAV gene therapy across its indications\: its proprietary AAV vector platform and its high-performing manufacturing platform. The company was founded in 2015, and the CEOs are Markus Hörer and Karl Christian Heller. Freeline Therapeutics was acquired by Ascend Gene & Cell Therapies Ltd. from Freeline Therapeutics Holdings Plc on February 10, 2023 for $25.83 million. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Freeline Therapeutics GmbH
Freeline Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Ascend Gene & Cell Therapies Ltd., Freeline Therapeutics GmbH is a German biotechnology company that focuses on liver directed gene therapies for bleeding disorders and other chronic diseases. The private company is based in Planegg, Germany. The company has a pipeline of gene therapies that have the potential to change the lives of people with chronic, debilitating diseases. Freeline has two key enabling platforms critical to realizing AAV gene therapy across its indications\: its proprietary AAV vector platform and its high-performing manufacturing platform. The company was founded in 2015, and the CEOs are Markus Hörer and Karl Christian Heller. Freeline Therapeutics was acquired by Ascend Gene & Cell Therapies Ltd. from Freeline Therapeutics Holdings Plc on February 10, 2023 for $25.83 million. | Commercial Services |